First-Line Tyrosine Kinase Inhibitor with or Without Aggressive Upfront Local Radiation Therapy in Patients with EGFRm Oligometastatic Non-Small-Cell Lung Cancer: Interim Results of a Randomized Phase III, Open-Label Clinical Trial (SINDAS) (NCT02893332)